PEDIATRIC INFLUENZA LEADERSHIP FORUM
LIVE

Serial Number

97668718

Owner

Seqirus Inc.

Attorney

Nancy Sabarra

Filing Date

Nov 8, 2022

Add to watchlist:

No watchlists yet
View on USPTO

PEDIATRIC INFLUENZA LEADERSHIP FORUM Trademark

Serial Number: 97668718

PEDIATRIC INFLUENZA LEADERSHIP FORUM is a trademark filed by Seqirus Inc. on November 8, 2022. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Seqirus Inc. (94 trademarks)

475 Green Oaks Parkway
Holly Springs, NC 27540

Entity Type: 03

Trademark Details

Filing Date

November 8, 2022

Registration Date

Not Registered

Published for Opposition

January 2, 2024

Goods & Services

Educational services in the nature of seminars in the fields of leadership, medicine, pharmaceuticals, vaccines, and influenza and distribution of educational materials in connection therewith; leadership training programs in the fields of medicine, pharmaceuticals, vaccines, and influenza and distribution of educational materials in connection therewith; arranging and conducting conferences and meetings in the fields of leadership, medicine, pharmaceuticals, vaccines, and influenza

Promoting awareness of influenza immunization and vaccination programs; providing business consulting and consumer information services related to pharmaceuticals and vaccines; providing a website for practice management and administrative support services to healthcare providers, medical professionals, and pharmacies; providing online information for healthcare providers, medical professionals, and pharmacies about practice management and administrative support related to pharmaceuticals and vaccines; business management consultation in the field of leadership development

Pharmaceutical research and development; medical research services; providing medical and scientific research in the fields of pharmaceuticals, vaccines, and influenza; providing information in the fields of pharmaceutical and vaccine research and development and influenza research; providing a website featuring information in the fields of pharmaceutical and vaccine research and influenza research; consulting services related to research and development of medicines, pharmaceuticals, and vaccines; technical consulting in the field of pharmaceutical studies

Medical services; health care services; medical information services; providing a website with medical information in the fields of influenza and the prophylactic and therapeutic properties of pharmaceuticals and vaccines; providing medical information in the fields of influenza and the prophylactic and therapeutic properties of pharmaceuticals and vaccines; pharmaceutical consultation; consulting services relating to the prophylactic and therapeutic properties of vaccines

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 17, 2026 EXRA
SOU EXTENSION 5 GRANTED
Aug 16, 2026 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 13, 2026 AITU
SOU TEAS EXTENSION RECEIVED
May 21, 2026 EEXT
SOU EXTENSION 5 FILED
May 20, 2026 EXT5
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 28, 2026 EXRA
SOU EXTENSION 4 GRANTED
Feb 17, 2026 EX4G
SOU EXTENSION 4 FILED
Feb 17, 2026 EXT4
SOU TEAS EXTENSION RECEIVED
Feb 17, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 27, 2025 EXRA
SOU EXTENSION 3 GRANTED
Aug 26, 2025 EX3G
SOU EXTENSION 3 FILED
Aug 26, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Aug 26, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 26, 2025 EXRA
SOU EXTENSION 2 GRANTED
Feb 25, 2025 EX2G
SOU EXTENSION 2 FILED
Feb 25, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Feb 25, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 26, 2024 EXRA
SOU EXTENSION 1 GRANTED
Aug 26, 2024 EX1G
SOU EXTENSION 1 FILED
Aug 26, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Aug 26, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 27, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 2, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jan 2, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 13, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 24, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 22, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 21, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 21, 2023 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Aug 18, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Aug 18, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 22, 2023 GNRN
NON-FINAL ACTION E-MAILED
May 22, 2023 GNRT
NON-FINAL ACTION WRITTEN
May 22, 2023 CNRT
ASSIGNED TO EXAMINER
May 15, 2023 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Feb 21, 2023 AMPX
ASSIGNED TO LIE
Feb 21, 2023 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
Dec 15, 2022 PARI
NOTICE OF DESIGN SEARCH CODE E-MAILED
Nov 30, 2022 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 29, 2022 NWOS
NEW APPLICATION ENTERED
Nov 11, 2022 NWAP